Logotherapy Counseling Programme for Palliative Care Patients With Chronic Sorrow

Sponsor
Baskent University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05129059
Collaborator
(none)
58
1
2
12.4
4.7

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of logotherapy counseling program on chronic sorrow, meaning of life and dignity of palliative care patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Logotherapy
N/A

Detailed Description

Palliative care patients experience psychosocial and spiritual problems such as depressed mood, fear of metastasis, uncertainty, lack of pleasure, fear of suffering, and chronic sorrow. Logotherapy is a meaning-centered intervention helping the individual to discover the meaning of life and increasing the spiritual well-being and quality of life of the individual. In this study, the effect of logotherapy counseling program on dignity, chronic sorrow and meaning of life of palliative care patients will be evaluated.

In this study, the participants will be randomized in a single blind manner (participant) to either intervention (8 session-4 week logotherapy) or control (routine care) groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
58 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Logotherapy Counseling Programme on Dignity and Chronic Sorrow in Palliative Care Patients Experiencing Chronic Sorrow
Actual Study Start Date :
Jan 19, 2021
Anticipated Primary Completion Date :
Jan 1, 2022
Anticipated Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Logotherapy

Participants will receive individual logotherapy counseling by the investigator for 8 visits in 4 weeks.

Other: Logotherapy
Logotherapy is a method of finding meaning with three basic principles. The first principle is that life is meaningful in every situation , even in the most desperate moments. The second principle is that the main source of motivation is the desire to find meaning in life. The third is that an individual is free to choose his own attitude even in the worst conditions.

No Intervention: Control

Participants will receive routine care.

Outcome Measures

Primary Outcome Measures

  1. meaning in life [baseline and 8 weeks]

    Meaning in life scale is a validated, 7-points Likert type scale with 2 dimensions. Possible scores range from 5 to 35 for each dimensions. Change= score of present meaning subscale> searched meaning subscale (8 week subscale-baseline subscale

  2. dignity [baseline and 8 weeks]

    The Patient Dignity Inventory is a valid, 5-points Likert type scale with 5 dimensions. Possible scores range from 25-125. Change= Lower score from the patient dignity inventory at the end of intervention compared to baseline.

  3. chronic sorrow [baseline and 8 weeks]

    Prolonged grief disorder scale-patient form is a valid, 5-points Likert type scale. Possible scores range from 12 to 60. Change= Lower score from the scale at the end of intervention compared to baseline.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Hospitalized patients due to advanced cancer Patients informed of cancer diagnosis at least 1 month Patients reporting to have chronic sorrow Patients with palliative performance scale score at least 50% Patients having life expectancy more than 6 months Patients who volunteered to participate in the study and signed written informed consent

Exclusion Criteria:

Clinically diagnosed mental disorder Patients with palliative performance scale score < 40%

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gazi University Hospital Ankara Turkey 06560

Sponsors and Collaborators

  • Baskent University

Investigators

  • Principal Investigator: Yasemin Eskigülek, Baskent University
  • Study Director: Sultan Kav, Baskent University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yasemin Eskigülek, RN, MSN, Baskent University
ClinicalTrials.gov Identifier:
NCT05129059
Other Study ID Numbers:
  • KA21/276
First Posted:
Nov 22, 2021
Last Update Posted:
Dec 2, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yasemin Eskigülek, RN, MSN, Baskent University

Study Results

No Results Posted as of Dec 2, 2021